Today
+3.01%
5 Days
+4.00%
1 Month
+10.98%
6 Months
+21.31%
Year to Date
+38.29%
1 Year
+27.37%
• Anheuser-Busch InBev saw price momentum driven by institutional buying and solid fundamentals. • The company reported annual revenue of $59.32B and net profit of $6.84B. • Analysts rate the stock a Buy with an average price target of $95.56.
• Altria shares rose due to strong demand for defensive consumer staples amid market volatility. • The company increased its dividend, supported by strong operating cash flows and pricing power. • Technical indicators show a MACD buy signal and an overbought Williams %R.
• Philip Morris attracted institutional buying due to its resilient balance sheets and dividends. • Smoke-free products drive momentum, generating over forty percent of total revenues. • Analysts maintain buy ratings with an average price target of $202.09.
• Macroeconomic headwinds and sector weakness pressured Anheuser-Busch InBev stock downwards. • Technical indicators show a MACD sell signal and oversold conditions. • Analysts maintain positive ratings with an average price target of $97.17.
• Management raised full-year and third-quarter adjusted earnings per share guidance. • ZYN oral nicotine pouch growth drives smoke-free product momentum. • Annual revenue reached $40.65B with net profit totaling $11.32B.
• Philip Morris USA announced a strategic contract manufacturing arrangement with PMI affiliates. • Institutional capital inflows were driven by high dividend yields and resilient cash flow. • Altria reported annual revenue of $20.14B and a net profit of $6.93B.


| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.52% |
| BlackRock Institutional Trust Company, N.A. | 5.57% |
| State Street Investment Management (US) | 4.36% |
| Charles Schwab Investment Management, Inc. | 3.92% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 39.05% |
| Investment Advisor/Hedge Fund | 17.61% |
| Research Firm | 2.66% |
| Bank and Trust | 1.52% |
Related Instruments